|
|
|
|
Direct Cost |
Indirect Cost |
|
1F99CA253749-01 |
Characterizing Chromatin Remodeling Mechanisms of Chemo-Sensitivity and Resistance in Pediatric Solid Tumors |
VAN ANDEL INSTITUTE GRADUATE SCHOOL |
NCI |
$46,020 |
|
$46,020 |
1R01AG066764-01A1 |
Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence. |
VAN ANDEL RESEARCH INSTITUTE |
NIA |
$324,502 |
$272,530 |
$597,032 |
1R01AG067426-01 |
Alzheimers disease genetic architecture in the Portuguese population |
VAN ANDEL RESEARCH INSTITUTE |
NIA |
$280,731 |
$252,658 |
$533,389 |
1R01HL153219-01 |
Structural and functional studies of the human TRPM4 and TRPM5 channels |
VAN ANDEL RESEARCH INSTITUTE |
NHLBI |
$305,156 |
$274,640 |
$579,796 |
1R01NS112363-01A1 |
Structural and functional studies of CALHM channels |
VAN ANDEL RESEARCH INSTITUTE |
NINDS |
$249,113 |
$224,202 |
$473,315 |
1R01NS113894-01A1 |
Epigenetic contributions to symptom asymmetry in Parkinsons disease |
VAN ANDEL RESEARCH INSTITUTE |
NINDS |
$235,000 |
$211,500 |
$446,500 |
1R01NS114409-01A1 |
The contribution of the vermiform appendix to Parkinsons disease |
VAN ANDEL RESEARCH INSTITUTE |
NINDS |
$235,000 |
$211,500 |
$446,500 |
1R01NS117137-01A1 |
Exploring mechanisms of Parkinsons disease-linked D620N VPS35 in rat models |
VAN ANDEL RESEARCH INSTITUTE |
NINDS |
$235,000 |
$211,500 |
$446,500 |
1R21AI153997-01 |
Chromatin architecture as a determinant of dendritic cell function |
VAN ANDEL RESEARCH INSTITUTE |
NIAID |
$150,000 |
$135,000 |
$285,000 |
1R35GM138321-01 |
Elucidating structures and molecular mechanisms of Pannexin channels |
VAN ANDEL RESEARCH INSTITUTE |
NIGMS |
$250,000 |
$225,000 |
$475,000 |
2R15AI096991-03 |
Roles of endothelial cells in HIV infection and latency in resting CD4+ T cells |
CALVIN UNIVERSITY |
NIAID |
$300,000 |
$62,411 |
$362,411 |
3R35GM131754-02S1 |
Cryo-EM high performance data storage |
VAN ANDEL RESEARCH INSTITUTE |
NIGMS |
$100,000 |
|
$100,000 |
3R44MH107077-02A1S1 |
PDE4D PET Ligand |
TETRA DISCOVERY PARTNERS, INC. |
NIMH |
|
|
$625,084 |
5F31CA236300-02 |
Development of Mithramycin Analogues to Target Transcriptional Vulnerabilities in Rhabdoid Tumor |
VAN ANDEL RESEARCH INSTITUTE |
NCI |
$44,520 |
|
$44,520 |
5F32CA225043-03 |
The Role of the Epigenetic Regulator UHRF1 in Colon Tumorigenesis |
VAN ANDEL RESEARCH INSTITUTE |
NCI |
$69,306 |
|
$69,306 |
5F99CA245821-02 |
DNA methylation regulation through the UHRF1 oncoprotein |
VAN ANDEL INSTITUTE GRADUATE SCHOOL |
NCI |
$44,520 |
|
$44,520 |
5R01AG061086-02 |
Role of Desumoylase SENP6 in Joint Aging and Osteoarthritis Development |
VAN ANDEL RESEARCH INSTITUTE |
NIA |
$262,363 |
$236,127 |
$498,490 |
5R01AI070285-14 |
Structural biology of proteostasis in M. tuberculosis |
VAN ANDEL RESEARCH INSTITUTE |
NIAID |
$250,000 |
$225,000 |
$475,000 |
5R01CA204020-06 |
Role of GAS41 in Human Cancer |
VAN ANDEL RESEARCH INSTITUTE |
NCI |
$228,750 |
$205,875 |
$434,625 |
5R01CA212374-04 |
Visualization and Epigenomic Characterization of Early Intestinal Tumorigenesis in Mice |
VAN ANDEL RESEARCH INSTITUTE |
NCI |
$228,750 |
$205,875 |
$434,625 |